Immunization News and Research

RSS

Evaluation of the potential of new and repurposed TB vaccines

A new study evaluated effective vaccination strategies for two TB vaccines, M72/AS01E and BCG.

5 May 2022

The war against COVID-19: reinfection, vaccines, and herd immunity

A communication published in the journal Epidemiologia aimed to answer several questions concerning neutralizing antibodies against SARS-CoV-2, herd immunity, and COVID-19 vaccines.

4 May 2022

The extent to which COVID-19 vaccination rates and vaccine hesitancy are associated with levels of online vaccine misinformation

A new study has determined the link between vaccine hesitancy, vaccination rates, and online misinformation across the US.

4 May 2022

Researchers reveal the mechanism of action of century-old BCG vaccine

The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world's oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic TB, it has surprisingly been found to protect newborns and young infants against multiple bacterial and viral infections unrelated to TB. There's even some evidence that it can reduce severity of COVID-19.

4 May 2022

Researchers investigate the population-level consequences of wearing masks

McMaster University researchers who study the dynamics of infectious disease transmission have investigated the population-level consequences of a potentially significant––and unobvious––benefit of wearing masks.

4 May 2022

Scientists discover a potential new method of active immunization to prevent Alzheimer's disease

During experiments in animal models, researchers at the University of Kansas have discovered a possible new approach to immunization against Alzheimer's disease (AD).

4 May 2022

Multivalent messenger ribonucleic acid-lipid nanoparticle vaccines against SARS-CoV-2

A new study analyzed multivalent messenger ribonucleic acid (mRNA)-lipid nanoparticle (LNP) vaccine constructs against certain β-coronaviruses (β-CoVs).

3 May 2022

The generation of SARS-CoV-2 virus-like particles in insect cells

Researchers have reported the development of a promising COVID-19 vaccine candidate which is based on SARS-CoV-2 VLPs, derived from the co-expression of the spike, membrane, and envelope structural proteins in the baculovirus expression system.

2 May 2022

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

By using data representing 80% of the US population, researchers have found that increased vaccination coverage against COVID-19 can be linked to a reduced incidence of cases and deaths.

2 May 2022

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

In a new study, researchers described their self-designed chimeric receptor-binding domain-dimer vaccine approach to adapt SARS-CoV-2 variants of concern and variants of interest.

29 Apr 2022

Exploring oncolytic viral therapeutics and immunotherapies derived from DNA and RNA

A new review initially described the developments in cancer-based medicines that included vaccinations, vector-based techniques, and genome injection using DNA and RNA-based nucleic acid therapeutics.

28 Apr 2022

Study describes ultra-structure of Nipah virus surface glycoprotein

A team of US-based scientists has recently demonstrated the cryo-electron microscopic structure and antigenicity of the attachment glycoprotein of the Nipah virus.

27 Apr 2022

Does re-freezing COVID-19 mRNA vaccines affect immunogenicity?

A new study published in the journal Vaccines evaluated if re-freezing coronavirus disease 2019 (COVID-19) mRNA vaccine vials preserved the immunogenicity.

27 Apr 2022

Survey identifies maternal attitude towards COVID-19 vaccination during pregnancy

Researchers designed a survey to investigate whether maternal beliefs were associated with COVID-19 vaccine-hesitancy during pregnancy.

27 Apr 2022

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

As part of World Immunization Week 2022, News Medical speaks to Thabani Maphosa, the Managing Director of Country Programmes at Gavi, The Vaccine Alliance, about their work to increase equitable and sustainable use of vaccines by maximizing financial investments, bringing the best partners to the table and driving innovation.

27 Apr 2022

Immunization News and Research

Evaluation of the potential of new and repurposed TB vaccines

The war against COVID-19: reinfection, vaccines, and herd immunity

The extent to which COVID-19 vaccination rates and vaccine hesitancy are associated with levels of online vaccine misinformation

Researchers reveal the mechanism of action of century-old BCG vaccine

Researchers investigate the population-level consequences of wearing masks

Scientists discover a potential new method of active immunization to prevent Alzheimer's disease

Multivalent messenger ribonucleic acid-lipid nanoparticle vaccines against SARS-CoV-2

The generation of SARS-CoV-2 virus-like particles in insect cells

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

Exploring oncolytic viral therapeutics and immunotherapies derived from DNA and RNA

Study describes ultra-structure of Nipah virus surface glycoprotein

Does re-freezing COVID-19 mRNA vaccines affect immunogenicity?

Survey identifies maternal attitude towards COVID-19 vaccination during pregnancy

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

Highly Effective Single-Dose HPV Vaccination for the Eradication of Cervical Cancer

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

Eradicating Polio; What's it going to take?

The long-term impact of prior SARS-CoV-2 infection on immune responses after COVID-19 vaccination

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News